Home > Insider Trading > Filing (0001012975-14-000212)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513818	Versartis Inc.	VSAR	Pharmaceutical Preparations (2834)	244106690

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1192212	O. Philippe Chambon	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No
1231092	James Niedel	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No
1247851	Ronald Hunt	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No
1340806	K Vijay Lathi	C/O New Leaf Ventures 1200 Park Place, Suite 300 San Mateo CA 94043	No	No	Yes	No
1441439	New Leaf Ventures Ii, L.p.	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	Yes	No	Yes	No
1441563	Jeani Delagardelle	C/O New Leaf Ventures 1200 Park Place, Suite 300 San Mateo CA 94043	No	No	Yes	No
1441857	New Leaf Venture Management Ii, L.l.c.	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	Yes	No	Yes	No
1441858	New Leaf Venture Associates Ii, L.p.	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	Yes	No	Yes	No
1547100	Liam Ratcliffe	C/O New Leaf Ventures Times Square Tower, 7 Times Sq, Ste 3502 New York NY 10036	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-03-27	1,821,084	$0.00	1,821,084	No	4	C	Direct
Common Stock	Acquisiton	2014-03-27	733,880	$0.00	2,554,964	No	4	C	Direct
Common Stock	Acquisiton	2014-03-27	265,219	$0.00	2,820,183	No	4	C	Direct
Common Stock	Acquisiton	2014-03-27	117,342	$0.00	2,937,525	No	4	C	Direct
Common Stock	Acquisiton	2014-03-27	308,356	$0.00	3,245,881	No	4	C	Direct
Common Stock	Acquisiton	2014-03-27	66,049	$0.00	3,311,930	No	4	C	Direct
Common Stock	Acquisiton	2014-03-27	60,000	$21.02	3,371,930	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2014-03-27	20,942,466	$0.00	1,821,084	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2014-03-27	8,439,620	$0.00	733,880	$0.00
Common Stock	Series D1 Convertible Preferred Stock	Disposition	2014-03-27	3,050,019	$0.00	265,219	$0.00
Common Stock	Series D2 Convertible Preferred Stock	Disposition	2014-03-27	1,349,433	$0.00	117,342	$0.00
Common Stock	Series E Convertible Preferred Stock	Disposition	2014-03-27	3,546,094	$0.00	308,356	$0.00
Series B Convertible Preferred Stock	Warrant	Disposition	2014-03-27	759,565	$0.00	759,565	$0.45
Common Stock	Series B Convertible Preferred Stock	Disposition	2014-03-27	759,565	$0.00	66,049	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	X	Direct
No	4	C	Direct

Footnotes

The shares automatically converted into Common Stock on a 1-for-11.5 basis upon the closing of the Issuer's initial public offering without payment of further consideration and had no expiration date.
Represents shares directly beneficially owned by NLV II. New Leaf Venture Associates II, L.P. ("NLV Associates") is the general partner of NLV II and New Leaf Venture Management II, L.L.C. ("NLV Management") is the general partner of NLV Associates. Philippe O. Chambon, Jeani Delagardelle, Ronald Hunt, Vijay Lathi, James Niedel and Liam Ratcliffe are the individual managers of NLV Management (the "Individual Managers"). NLV Associates and NLV Management disclaim beneficial ownership of such shares, except to the extent of their pecuniary interest therein. As one of six individual managers, each of the Individual Managers disclaims beneficial ownership over the shares reported herein, and in all events disclaims pecuniary interest except to the extent of his economic interest.
Immediately exercisable. The warrant shall expire on the earlier of October 12, 2017 or the closing of the Issuer's initial public offering.